Stock SRDX SURMODICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Surmodics, Inc.

Equities

SRDX

US8688731004

Real-time Estimate Cboe BZX
Other stock markets
 01:13:02 2024-06-10 pm EDT 		5-day change 1st Jan Change
41.83 USD -0.29% Intraday chart for Surmodics, Inc. -0.48% +15.13%
03:45pm Surmodics Signs Group Purchasing Deal With Premier MT
May. 30 Barrington Research Downgrades SurModics to Market Perform From Outperform MT

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company has insufficient levels of profitability.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SURMODICS, INC. Stock Surmodics, Inc.
+15.16% 598M
C
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.14% 187B
C+
MEDTRONIC PLC Stock Medtronic plc
+0.44% 110B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.18% 69.54B
A
CENCORA, INC. Stock Cencora, Inc.
+13.38% 46.37B
B-
DEXCOM, INC. Stock DexCom, Inc.
-6.98% 46.05B
B-
HOYA CORPORATION Stock Hoya Corporation
+7.97% 42.54B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+18.16% 30.72B
B
TERUMO CORPORATION Stock Terumo Corporation
+17.70% 25.62B
A-
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-7.56% 23.32B
B
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SRDX Stock
  4. Ratings Surmodics, Inc.